Regenovo
Biomedical 3D printing technology was one of the most talked-about subjects in the 3D printing arena last year - and 2014 may see even more exciting developments in this sphere.
High-tech enterprise providing integrated solutions in 3D printing technology for biomedical applications Regenovo Biotechnology has kicked off the year by showcasing its new Regenovo 3D bio-printer at the globally-renowned International CES 2013 expo in Las Vegas.
Rather than building using layers of plastic or metal, the bio-printer uses biological material and living cells in the same layering process to create real living tissue.
Regenovo can put different cells and materials into designated places to form complex 3D models. The designed architecture facilitates cell growth, organisation and differentiation.
Among the scintillating device's advantages are its capability to print high viscosity materials, low cell damage rate in the printing process and the fact the system is suitable for assembling under sterile conditions.
Artificial human body parts can theoretically be printed for transplant and Regenovo Biotechnology's next goal is to begin building artificial livers and kidneys for transplant, although this may not be achieved for another 15-20 years.
3D printing biological materials is becoming an important development across the planet, with the ability to recreate muscles, tendons and organs having the potential to change medical science as we know it.
